HCA Healthcare, Inc. (HCA) vs Moderna, Inc. (MRNA)

A side-by-side comparison of HCA Healthcare, Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 3, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HCA vs MRNA

growth of $100 · dividends reinvested · last 8y
HCA +220.1% (+15.7%/yr)MRNA +921.6% (+33.7%/yr)MRNA compounded faster over this window
05001k2k2k3kStart $1002020202220242026$320$1,022
HCA MRNA

HCA vs MRNA: by the numbers

  • •HCA is the larger company ($92.38B vs $75.39B market cap).
  • •HCA is profitable (8.77% net margin) while MRNA runs a net loss (-141.43%).
  • •MRNA grew revenue faster over the past five years (19.33% vs 6.85% CAGR).
  • •HCA pays a dividend (0.72% yield), while MRNA has no payments in the available dividend history.

Metrics side by side

Valuation

MetricHCAMRNA
P/E ratio14.28N/A
Forward P/E14.48N/A
PEG ratio0.68N/A
P/S ratio1.1833.84
P/B ratioN/A11.15
EV / EBITDA8.90N/A
FCF yield6.49%N/A

Profitability

MetricHCAMRNA
Gross margin41.50%55.35%
Operating margin15.48%-158.13%
Net margin8.77%-141.43%
ROEN/A-46.61%
ROIC19.41%-39.16%

Dividends

MetricHCAMRNA
Dividend yield0.72%N/A
Payout ratio10.24%N/A

Growth (annualized)

MetricHCAMRNA
Revenue CAGR (5Y)6.85%19.33%
EPS CAGR (5Y)20.90%N/A
FCF CAGR (5Y)56.45%N/A
Total return CAGR (5Y)12.41%-11.04%

Frequently asked

Which has grown faster, HCA or MRNA?
Over the past five years, MRNA grew revenue faster — HCA at a 6.85% CAGR versus MRNA at 19.33%.
Does HCA or MRNA pay a bigger dividend?
HCA pays a dividend (0.72% yield), while MRNA has no payments in the available dividend history.
Is HCA or MRNA more profitable?
HCA runs the higher net margin — HCA at 8.77% versus MRNA at -141.43%.
How have HCA and MRNA total returns compared?
Over the past 5 years, HCA delivered 12.41% and MRNA delivered -11.04% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 3, 2026.